REVIV, a global brand in preventative health specialising in IV therapies, diagnostic, testing and cutting edge lifestyle genetics services, has announced the newest member to its advisory board. From June 1st, Max Johnson, former Goldman Sachs investment banker and CEO of MJ Capital will be joining REVIV.
Mr Johnson will serve REVIV as a Non-Executive Director. He has over 20 years of experience in Russia and Asia after graduating from Oxford and Tsinghua Universities with degrees in Russian, Polish, MBA and a certificate in Management from MIT. Before joining Goldman Sachs, Max worked across Asia in metals and mining. While at Goldman he was in the Investment Banking division’s M&A team for 4 years, then left to found his own business MJ Capital, a boutique investment and advisory business focusing on raising capital in Asia. He has a strong interest in the health and wellness sector and co-founded a high-end fitness chain in the Philippines. He speaks fluent Russian, Polish, French, Mandarin and is a black belt in Taekwondo.
On joining REVIV, Mr Johnson said: “REVIV first came to my attention when they opened in Hong Kong, and back then I could see that REVIV is a game-changer, and so I am totally honoured to join the Board at this time. The global pandemic has made everyone stop and assess their priorities in life. Health is top of the list. We all need better and smarter health solutions, and REVIV is the company to become the world standard in preventative health. I look forward to helping REVIV with its upcoming financing round and achieving its global ambitions”.
Sarah Lomas, the CEO & President of REVIV Global, has commented: “The appointment of Max Johnson comes at an exciting and critical point in our shift to the Med-Tech sector. Having built a global preventative health brand in 41 countries, we are ready for aggressive growth. The current pandemic has created unprecedented investment opportunities for REVIV. It is my responsibility to pursue these with a strong capital deployment strategy behind every decision we make, Max has a wealth of experience, and will work directly with the executive board in such funding projects.”